Resection of Colorectal Liver Metastases After Second-Line Chemotherapy: Is It Worthwhile? A LiverMetSurvey Analysis of 6415 Patients

Submitted by Ana Quininha (ana.quininha@chlc.min-saude.pt) on 2018-03-02T15:20:23Z No. of bitstreams: 1 Eur J Cancer 2017 7.pdf: 734043 bytes, checksum: 54e766392f67d2f76df232c0b79eab2a (MD5)

Bibliographic Details
Main Author:	Adam, R (author)
Other Authors:	Yi, B (author), Innominato, PF (author), Barroso, E (author), Laurent, C (author), Giuliante, F (author), Capussotti, L (author), Lapointe, R (author), Regimbeau, JM (author), Lopez-Ben, S (author), Isoniemi, H (author), Hubert, C (author), Lin, JK (author), Gruenberger, T (author), Elias, D (author), Skipenko, OG (author), Guglielmi, A (author)
Format:	article
Language:	eng
Published:	2018
Subjects:	Antibodies, Monoclonal Antineoplastic Combined Chemotherapy Protocols Camptothecin Catheter Ablation Cetuximab Disease Progression Disease-Free Survival Female Hepatectomy Humans Liver Neoplasms Lymphatic Metastasis Male Middle Aged Postoperative Care Preoperative Care Prospective Studies Registries Colonic Neoplasms Rectal Neoplasms CHLC CHBPT
Online Access:	http://hdl.handle.net/10400.17/2922
Country:	Brazil
Oai:	oai:repositorio.chlc.min-saude.pt:10400.17/2922

Internet

http://hdl.handle.net/10400.17/2922